Table 3.

GAHT intake behaviours outside the reference GAHT regimen among trans people who were previously or currently on GAHT, stratified by gender (N=151)

	n	%†
Trans women and transfeminine people* taking GAHT outside reference regimen (N=125)
Taking oral contraceptive pills (OCP) containing ethinyl oestradiol	86	68.8
Taking non-recommended forms of anti-androgen	30	24.0
Taking OCP with other oestradiol simultaneously	28	22.4
Not taking antiandrogens despite having testes	16	12.8
Taking antiandrogens alone	7	7.2
Taking oral phytoestrogen	6	4.8
Trans men taking GAHT outside the reference regimen (N=26)
Taking oral anabolic steroids alone	20	76.9
Injecting non-recommended testosterone esters	3	11.5
Injecting two different formulations of testosterone esters simultaneously	3	11.5

*Includes three non-binary individuals who self-identified as transfeminine.

†Percentages do not sum up to 100% as there were multiple characteristics for a patient taking hormones outside the reference regimen.

GHAT, gender-affirming hormonal therapy.